Arnaud Pauline, Milleron Olivier, Hanna Nadine, Ropers Jacques, Ould Ouali Nadia, Affoune Amel, Langeois Maud, Eliahou Ludivine, Arnoult Florence, Renard Philippe, Michelon-Jouneaux Marlène, Cotillon Marie, Gouya Laurent, Boileau Catherine, Jondeau Guillaume
Université de Paris, LVTS, INSERM U1148, Hôpital Bichat-Claude-Bernard, Paris, France.
Centre National de Reference pour le Syndrome de Marfan et les Syndromes Apparentés, VASCERN HTAD European Reference Centre, AP-HP, Hôpital Bichat-Claude-Bernard, Paris, France.
Genet Med. 2021 Jul;23(7):1296-1304. doi: 10.1038/s41436-021-01132-x. Epub 2021 Mar 17.
PURPOSE: Marfan syndrome (MFS) is a connective tissue disorder in which several systems are affected with great phenotypic variability. Although known to be associated with pathogenic variants in the FBN1 gene, few genotype-phenotype correlations have been found in proband studies only. METHODS: In 1,575 consecutive MFS probands and relatives from the most comprehensive database worldwide, we established survival curves and sought genotype-phenotype correlations. RESULTS: A risk chart could be established with clinical and genetic data. Premature termination codon variants were not only associated with a shorter life expectancy and a high lifelong risk of aortic event, but also with the highest risk of severe scoliosis and a lower risk for ectopia lentis (EL) surgery. In-frame variants could be subdivided according to their impact on the cysteine content of fibrillin-1 with a global higher severity for cysteine loss variants and the highest frequency of EL surgery for cysteine addition variants. CONCLUSION: This study shows that FBN1 genotype-phenotype correlations exist for both aortic and extra-aortic features. It can be used for optimal risk stratification of patients with a great importance for genetic counseling and personalized medicine. This also provides additional data for the overall understanding of the role of fibrillin-1 in various organs.
目的:马凡综合征(MFS)是一种结缔组织疾病,其中多个系统受到影响,表型变异很大。尽管已知与FBN1基因的致病变异有关,但仅在先证者研究中发现的基因型-表型相关性很少。 方法:在来自全球最全面数据库的1575例连续的MFS先证者及其亲属中,我们建立了生存曲线并寻找基因型-表型相关性。 结果:可以根据临床和遗传数据建立风险图。过早终止密码子变异不仅与预期寿命缩短和主动脉事件的终身高风险相关,还与严重脊柱侧凸的最高风险和晶状体异位(EL)手术的较低风险相关。框内变异可根据其对原纤蛋白-1半胱氨酸含量的影响进行细分,半胱氨酸缺失变异的总体严重程度更高,半胱氨酸添加变异的EL手术频率最高。 结论:本研究表明,FBN1基因型-表型相关性在主动脉和主动脉外特征中均存在。它可用于患者的最佳风险分层,对遗传咨询和个性化医疗非常重要。这也为全面了解原纤蛋白-1在各个器官中的作用提供了额外的数据。
Drug Des Devel Ther. 2025-8-26
J Vitreoretin Dis. 2025-8-22
JACC Adv. 2025-8-8
J Mol Cell Cardiol Plus. 2025-6-19
Orphanet J Rare Dis. 2025-7-11
JRSM Cardiovasc Dis. 2025-6-17